Who Paid My Doc
Gtx-102-Cl302
ClinicalTrials.gov NCT06415344
Research payments
$1,777,941
Through program year 2025, $1,777,941 in research payments was reported against Gtx-102-Cl302, across 145 payments, paid by Ultragenyx Pharmaceutical Inc..
- Paid by
- Ultragenyx Pharmaceutical Inc.
- ClinicalTrials.gov
- NCT06415344
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,511,158 | 86 |
| 2024 | Research | $266,784 | 59 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Elizabeth Berry-Kravis Chicago, IL Named on 39 payments
- Lynne Bird San Diego, CA Named on 32 payments
- Han Phan Atlanta, GA Named on 28 payments
- Neha Bhatia Boston, MA Named on 21 payments
- Rajsekar Rajaraman Los Angeles, CA Named on 14 payments
- Srishti Nangia New York, NY Named on 7 payments
- Scott Batchelor Atlanta, GA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.